BlackRock’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-495,800
| Closed | -$58.7M | – | 5660 |
|
|
2021
Q1 | $58.7M | Buy |
495,800
+73,280
| +17% | +$8.67M | ﹤0.01% | 2520 |
|
|
2020
Q4 | $49.9M | Sell |
422,520
-48,431
| -10% | -$5.62M | ﹤0.01% | 2474 |
|
|
2020
Q3 | $52.3M | Buy |
470,951
+23,355
| +5% | +$2.51M | ﹤0.01% | 2274 |
|
|
2020
Q2 | $45.7M | Buy |
447,596
+62,703
| +16% | +$6.71M | ﹤0.01% | 2302 |
|
|
2020
Q1 | $41.5M | Sell |
384,893
-1,538
| -0.4% | -$177K | ﹤0.01% | 2174 |
|
|
2019
Q4 | $45M | Sell |
386,431
-34,624
| -8% | -$4.01M | ﹤0.01% | 2433 |
|
|
2019
Q3 | $48.2M | Buy |
421,055
+28,478
| +7% | +$2.83M | ﹤0.01% | 2308 |
|
|
2019
Q2 | $37.4M | Sell |
392,577
-25,424
| -6% | -$2.39M | ﹤0.01% | 2493 |
|
|
2019
Q1 | $38.1M | Sell |
418,001
-26,401
| -6% | -$2.16M | ﹤0.01% | 2414 |
|
|
2018
Q4 | $33.7M | Buy |
444,402
+6,347
| +1% | +$467K | ﹤0.01% | 2451 |
|
|
2018
Q3 | $35M | Sell |
438,055
-80,626
| -16% | -$7.51M | ﹤0.01% | 2572 |
|
|
2018
Q2 | $51.5M | Sell |
518,681
-407,731
| -44% | -$35.2M | ﹤0.01% | 2341 |
|
|
2018
Q1 | $75M | Buy |
926,412
+247,555
| +36% | +$20M | ﹤0.01% | 2027 |
|
|
2017
Q4 | $53.5M | Sell |
678,857
-38,693
| -5% | -$3.22M | ﹤0.01% | 2249 |
|
|
2017
Q3 | $66.2M | Sell |
717,550
-701,375
| -49% | -$67.4M | ﹤0.01% | 2097 |
|
|
2017
Q2 | $160M | Sell |
1,418,925
-89,171
| -6% | -$9.97M | 0.01% | 1458 |
|
|
2017
Q1 | $151M | Buy |
1,508,096
+1,318,183
| +694% | +$141M | 0.01% | 1498 |
|
|
2016
Q4 | $20.4M | Buy |
189,913
+78,375
| +70% | +$9.16M | 0.03% | 552 |
|
|
2016
Q3 | $13.9M | Buy |
111,538
+4,999
| +5% | +$590K | 0.02% | 642 |
|
|
2016
Q2 | $11.3M | Sell |
106,539
-15,416
| -13% | -$1.79M | 0.02% | 666 |
|
|
2016
Q1 | $14M | Buy |
121,955
+2,717
| +2% | +$319K | 0.02% | 598 |
|
|
2015
Q4 | $17M | Buy |
119,238
+13,727
| +13% | +$1.58M | 0.02% | 571 |
|
|
2015
Q3 | $9.48M | Sell |
105,511
-54,533
| -34% | -$5.76M | 0.01% | 646 |
|
|
2015
Q2 | $18.4M | Buy |
+160,044
| New | +$16.8M | 0.03% | 543 |
|
BlackRock's CBPO Position: Q2 2021 in Review
BlackRock sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 495,800 shares — an estimated $58.7M sold.
BlackRock first reported a position in CBPO in Q2 2015 and held it in 24 quarters. The position peaked at $160M in Q2 2017. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- BlackRock reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- BlackRock sold 495,800 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $58.7M.
- BlackRock first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 24 quarters.
- BlackRock's China Biologic Products Holdings, Inc. position peaked at $160M in Q2 2017.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.